Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Stavropolenergosbyt reported for 3 months of 2024 by RAS

4/26/24 STSB

EMC reported for 2023 by IFRS

4/26/24 GEMC

Agregat reported for 3 months of 2024 by RAS

4/26/24 AGRT

Sakhalinenergo reported for 3 months of 2024 by RAS

4/26/24 SLEN

Yandex reported for 3 months of 2024

4/26/24 YNDX

Purchase of Sistema Bank cost Samolet ₽1.5 billion

4/26/24 SMLT

Unipro's output in Q1 decreased by 0.5%

4/26/24 UPRO

Fix Price's LFL sales in Q1 started to improve

4/26/24 FIXP

Artgen reported for 2023 by IFRS

4/26/24 ABIO

Fix Price reported for 3 months of 2024 by IFRS

4/26/24 FIXP